Plain-English translation of NCT06687018 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial tests two different hands-on therapy techniques—Kaltenborn mobilisation and Mulligan mobilisation—to see which one is more effective at reducing pain, disability, and improving hand function in people with carpal tunnel syndrome. Both groups will also receive conventional treatment alongside their assigned therapy technique. The study will measure how much each treatment helps after 6 weeks.
Carpal tunnel syndrome causes pain, tingling, and numbness in the hand, but doctors want to find the most effective hands-on therapy approach to help patients feel better and regain hand function.
You likely qualify if…
You likely don't qualify if…
You will be randomly assigned to receive one of two hands-on therapy techniques—either Kaltenborn or Mulligan mobilisation—along with your regular conventional treatment. Over 6 weeks, you'll attend treatment sessions where a therapist will perform gentle mobilization of the bones in your wrist and hand. At the end of 6 weeks, you'll complete questionnaires about your pain, disability, and how well your hand is functioning.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Pakistan
Sponsor
Riphah International University
Enrollment target
~48 participants
Started
January 2024
Primary completion
January 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
20 Years – 45 Years
Last updated on clinicaltrials.gov in November 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Imran Amjad, Phd
Riphah International University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.